Skip to content

Trial Summary

A Non-Interventional Biomarker Study on the Molecular Evaluation of Archival Tumor Tissue in Subjects with Non-Small Cell Lung Cancer (NSCLC)

Acronym:

AMG 510 (BM)

ACTRN/NCT /ethics:

 

Scientific title:

A Non-Interventional Biomarker Study on the Molecular Evaluation of Archival Tumor Tissue in Subjects with Non-Small Cell Lung Cancer (NSCLC)

Trial & Patient Characteristics

Cancer TypeLung
Trial TypeEarly detection, diagnosis, prognosis
PhaseAll phases
Age Range18+ years
SexBoth
Tumour StreamNSCLC
Cancer StageAll stages
Anticipated Start Date-
Anticipated End Date-

Participating Hospitals

HospitalThe Queen Elizabeth Hospital
Clinical Trial CoordinatorPamela Cooper
Emailpamela.cooper@sa.gov.au
Phone08 8222 6410
Principal InvestigatorDr Rachel Roberts-Thomson
Recruitment StatusRecruiting